Skip to Main Content

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is mildly ambitious. We plan to putter around the castle, check in on the Pharmalot ancestors, and spend some mindless time in front of the telly. And what about you? This may be a good time to enjoy the great outdoors. You could boost the economy by placing some holiday gift orders or celebrate the virtues of free and fair elections. Or you could look in on someone feeling a bit isolated these days. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

U.S. infectious disease expert Anthony Fauci said vaccine developers should push to make billions of their Covid-19 vaccines to ensure access to all parts of the world, instead of focusing on the rich countries, Reuters says. Experts have raised doubts about access to the vaccine from Pfizer (PFE) and BioNTech (BNTX), especially in developing countries, because it needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below, posing infrastructure challenges.


The Infectious Diseases Society of America is evaluating the data on which U.S. regulators approved emergency use of an Eli Lilly (LLY) antibody treatment for Covid-19, and has noted that more information is needed, Reuters writes. The medical association, which represents more than 12,000 specialists, said its guidelines panel is evaluating available trial data and will issue its recommendations soon. The ISDA, which is also concerned about the limited supply of the drug, does not always follow the lead of the Food and Drug Administration.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!